Abstract:Prevalence of microbial infections and new rising pathogens are signified as causative agent for variety of serious and lethal health crisis in past years. Despite medical advances, bacterial and fungal infections continue to be a rising problem in the health care system. As more bacteria develop resistance to antibiotics used in therapy, and as more invasive microbial species develop resistance to conventional antimicrobial drugs. Relevant published publications from the last two decades, up to 2024, were systematically retrieved from the MEDLINE/PubMed, SCOPUS, EMBASE, and WOS databases using keywords such as quinolones, anti-infective, antibacterial, antimicrobial resistance and patents on quinolone derivatives. With an approach of considerable interest towards novel heterocyclic derivatives as novel anti-infective agents, researchers have explored these as essential tools in vistas of drug design and development. Among heterocycles, quinolones have been regarded extremely essential for the development of novel derivatives, even able to tackle the associated resistance issues. The quinolone scaffold with its bicyclic structure and specific functional groups such as the carbonyl and acidic groups, is indeed considered a valuable functionalities for further lead generation and optimization in drug discovery. Besides, the substitution at N-1, C-3 and C-7 positions also subjected to be having a significant role in anti-infective potential. In this article, we intend to highlight recent quinolone derivatives based on the SAR approach and anti-infective potential such as antibacterial, antifungal, antimalarial, antitubercular, antitrypanosomal and antiviral activities. Moreover, some recent patents granted on quinolone-containing derivatives as anti-infective agents have also been highlighted in tabular form. Due consideration of this, future research in this scaffold is expected to be useful for aspiring scientists to get pharmacologically significant leads.

Recent Advances of Quinones As a Privileged Structure in Drug Discovery

Quinoline as a Privileged Structure: A Recent Update on Synthesis and Biological Activities

Synthesis and Neuroprotective Biological Evaluation of Quinazolinone Derivatives Via Scaffold Hopping.

Synthesis and Pesticidal Activities of New Quinoxalines

Quinazoline derivatives and hybrids: recent structures with potent bioactivity

ChemInform Abstract: Recent Progress in Biological Activities and Synthetic Methodologies of Pyrroloquinoxalines

Application of Quinoline Ring in Structural Modification of Natural Products

Recent Updates on the Synthesis of Bioactive Quinoxaline-Containing Sulfonamides

Recent research on the physicochemical properties and biological activities of quinones and their practical applications: a comprehensive review

Therapeutic significance of quinolines: a patent review (2013-2015)

Quinolone scaffolds as potential drug candidates against infectious microbes: a review

Recent Advancements and Developments in the Biological Importance of Pyrimido[4,5‐b]Quinoline Scaffolds

A literature review on pharmacological aspects, docking studies, and synthetic approaches of quinazoline and quinazolinone derivatives

Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021–Present)

Multi-Targeting Exploration of New 2-Aminothiazolyl Quinolones: Synthesis, Antimicrobial Evaluation, Interaction with Dna, Combination with Topoisomerase Iv and Penetrability into Cells

A Comprehensive Review of Recent Advances in the Biological Activities of Quinazolines

Recent advances on quinoxalines as target‐oriented chemotherapeutic anticancer agents through apoptosis

The underrepresented quinolinone alkaloids in genera Penicillium and Aspergillus: structure, biology, and biosynthetic machinery

Pyridazine as a privileged structure: An updated review on anticancer activity of pyridazine containing bioactive molecules

Biologically active quinoline and quinazoline alkaloids part I

Quinolines and isoquinolines as HIV-1 inhibitors: Chemical structures, action targets, and biological activities